Free Trial

The Cooper Companies, Inc. (NASDAQ:COO) Stock Holdings Reduced by Renaissance Technologies LLC

Cooper Companies logo with Medical background

Renaissance Technologies LLC reduced its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 8.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 117,292 shares of the medical device company's stock after selling 10,500 shares during the quarter. Renaissance Technologies LLC owned 0.06% of Cooper Companies worth $10,783,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in COO. Byrne Asset Management LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $33,000. OFI Invest Asset Management bought a new position in Cooper Companies during the 4th quarter valued at $34,000. New Age Alpha Advisors LLC acquired a new position in shares of Cooper Companies during the 4th quarter valued at $38,000. West Financial Advisors LLC acquired a new position in shares of Cooper Companies during the 4th quarter valued at $49,000. Finally, Atala Financial Inc bought a new stake in shares of Cooper Companies in the 4th quarter worth $51,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 1.4 %

Shares of COO traded up $1.09 during mid-day trading on Tuesday, reaching $79.79. The company's stock had a trading volume of 2,200,120 shares, compared to its average volume of 1,418,396. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market cap of $15.96 billion, a price-to-earnings ratio of 40.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The business has a fifty day moving average of $82.52 and a 200 day moving average of $93.20.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on COO shares. Robert W. Baird lowered their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Piper Sandler restated an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, Citigroup cut their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $110.25.

Read Our Latest Stock Analysis on COO

About Cooper Companies

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

See Also

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines